Skip to main content

Table 3 Course of disease in 526 patients with confirmed or probable P. vivax mono-infection

From: Epidemiology and clinical features of vivax malaria imported to Europe: Sentinel surveillance data from TropNetEurop

 

Median

IQ-Range

Days from end of journey to onset (nmiss = 80)

60

8–149

   with chemoprophylaxis

86

41–158

   without chemoprophylaxis

31

4–133

Days in hospital (nmiss = 400)

4

2–5

 

N

% of non missing

In-patients (nmiss = 7)

312

60.1

Complications (nmiss = 256)

30

11.1

   indicating treatment failure

23

8.5

   indicating severe disease

7

2.6

Fatalities (nmiss = 0)

0

0.0

  1. Nmiss= Number of cases disregarded due to missing data; IQ-Range = Inter-quartile range